111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
Clinical trial NCT01445054 · TERMINATED
Trial details
- NCT number
- NCT01445054
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2014-08-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.